abstract |
The present invention provides a compound that is represented by the following general formula n n n n n n n n n n wherein R 1 , R 2 , R 4 , R 5 , R 6 , R 7 , X, W, X and Y are as defined in the specification. The compounds may be administered to treat DP1, FP, EP1, TP and/or EP4 receptor mediated diseases or conditions. |